# Totally Implantable Cochlear Implant (TICI): Feasibility Study

[](<warning: Undefined array key 0 in /code/wp-content/themes/hear-better/template-parts/hero/hero.php on line 71>)

[](<warning: Undefined array key 0 in /code/wp-content/themes/hear-better/template-parts/hero/hero.php on line 71>)

[](<warning: Undefined array key 0 in /code/wp-content/themes/hear-better/template-parts/hero/hero.php on line 71>)

[](<warning: Undefined array key 0 in /code/wp-content/themes/hear-better/template-parts/hero/hero.php on line 71>)

[](<warning: Undefined array key 0 in /code/wp-content/themes/hear-better/template-parts/hero/hero.php on line 71>)[](<warning: Undefined array key 0 in /code/wp-content/themes/hear-better/template-parts/hero/hero.php on line 71>)[](<warning: Undefined array key 0 in /code/wp-content/themes/hear-better/template-parts/hero/hero.php on line 71>)

 [hearbetter](https://hearbetter.medel.com/en-ca/) &gt; Totally Implantable Cochlear Implant (TICI): Feasibility Study 

 [    Back ](javascript:history.back()) 

     

 

#  Totally Implantable Cochlear Implant (TICI): Feasibility Study 

 

 ## **SCIENCE UPDATE**

*New scientific studies summarized for you*

### **Totally Implantable Cochlear Implant (TICI): Feasibility Study**

(Original title: Lefebvre, P.P., Müller, J., Mark, G. et al. Rehabilitation of human hearing with a totally implantable cochlear implant: a feasibility study. Commun Med 5, 10 (2025).)

### **Key message:**

Safety, hearing performance and user satisfaction with the TICI are comparable to conventional cochlear implants.

### **Background**

Cochlear implants (CIs) restore hearing in individuals with severe-to-profound hearing loss. Despite their proven benefits, CI uptake remains low. One reason is the external audio processor, its visibility, and its limitations for the user.

A totally implantable cochlear implant (TICI) was developed, combining all CI components in a single implant, invisible from the outside, eliminating the disadvantages of an external audio processor. The first-in-human study results of the TICI assessed its safety, hearing performance and user satisfaction.

### **Methods:**

- Non-randomized single group assignment
- Participants: 
    - 6 (4 female, 2 male) from 2 CI centers (Liège, Munich)
    - Mean age: 44.6 years
    - Bilateral severe to profound HL (&gt;70 dB HL)
- Within-subject comparison with TICI and external audio processor
- Data collection over 52 weeks
- Surgery and fitting: 
    - Standard surgical approach for conventional cochlear implants
    - First fitting 4 weeks post-op
- Outcome measures:
- Adverse events
- Speech perception in quiet (monosyllables) and in noise (sentence tests, SRT50)
- Subjective quality of life, subjective sound quality (HUI3, SSQ-12, HISQUI-19, NCIQ)
- Subjective user satisfaction: diary reports
- Device usage (hours per day): TICI data logging

### **Results:**

- Safety: 
    - Adverse event distribution is comparable to conventional CIs.
    - Adverse events: 15, of which 
        - Anticipated serious adverse device effect: 1 (swelling and infection signs at implantation site, successfully resolved without sequelae)
        - Unanticipated serious adverse device effects: 0

- Hearing performance and user satisfaction: 
    - Speech perception in quiet and noise with the TICI was similar to the CI used with an external audio processor (within-subject comparison) as well as comparable to conventional CIs.
    - Patient-reported outcome measures and user satisfaction scores all increased over the study duration.
    - 5 of 6 participants used the TICI without an external processor most of the time.

Read the full paper here (Open Access): [Rehabilitation of human hearing with a totally implantable cochlear implant: a feasibility study | Communications Medicine](https://www.nature.com/articles/s43856-024-00719-0)

 

 

##  Sign for new updates 

 By subscribing to our newsletter, you stay up-to-date on the best practices in hearing implant technology.

   Subscribe  

Information about MED-EL’s privacy policy can be found [here](https://www.medel.com/privacy-policy).

 

  A valid email is required.